Membership Orientation » Cancer Institute » UF Health Cancer Institute

The University of Florida Health Cancer Institute boasts a membership of more than 360 researchers and clinicians from across the University of Florida and UF Health, the Southeast’s most comprehensive academic health center. It is the only NCI-designated cancer center at a public institution in Florida. The Cancer Institute and its members are dedicated to providing leading-edge cancer care and conducting original research for the prevention, early diagnosis and treatment of cancer.

The mission of the UF Health Cancer Institute is to prevent, detect and ultimately cure cancer and address the unique challenges of the cancer burden faced by the population we serve by facilitating innovative, collaborative, transdisciplinary cancer research. The Cancer Institute will achieve these goals through discovery and research innovations in cancer mechanisms, prevention, screening and treatment, while training the next generation of cancer scientists and leaders and engaging the communities and populations we serve.

Explore our strategic plan — a roadmap to achieve our organizational goals and fuel our mission’s success. Our catchment area comprises 26 contiguous counties in North Florida, with 3.4 million people. Residents from the catchment area account for 80% of the patients seen at UF Health. The 26 counties span the size of Southern New England.

Research Programs

FAQs

How does Research Services support members?

The Research Services Team manages the UF Health Cancer Institute’s pilot and exploratory study and bridge grant programs. They provide administrative support to the development of RFAs, intake of applications, peer review, and award setup for these projects. Additionally, the team can provide experienced support for budget development and proposal submissions.

How does Research Development support cancer researchers?

The Research Development Team of the UF Health Cancer Institute provides skilled support for researchers in all aspects of research project and publication development. The team has an extensive background in research and oncology clinical studies, giving it a unique skillset to review and edit grant proposals and publications.

Our Research Development team has also curated a library of templates, guiding documents and boilerplate statements for investigators to use in preparation of extramural grant submissions. It also maintains a listing of cancer-relevant funding opportunities and distributes updates via the weekly Opportunity email newsletter. Subscribe to Opportunity.

How do Shared Resource reimbursement work?

ICBR Payment should be made by providing a chartfield to the ICBR lab. Credit Card and PCard payments are not captured on the reports used to calculate reimbursements. Once made reimbursements are processed on a monthly basis to qualifying full members (see membership policy for eligibility requirements).

Which supported Shared Resources are reimbursed?

Flow Cytometry and Confocal Microscopy and Next Generation Sequencing at 20% reimbursement. Biostatistics and Computational Biology is at no charge for initial consultation for proposal development.

How much of a reimbursement is given from the Cancer Institute on supported SRs?

20%.

How can the Clinical Research Office support my research interests?

The Clinical Research Office (CRO) supports member investigators in developing their own concepts into research protocols (Project Management Office), facilitating internal submissions and reviews to open trials that may be suitable for our patients, and offering a navigation tool that can be used to refer patients to appropriate trials in real time (Clinical Trial NaviGATOR). The Cancer Institute also has a grants team that can help prepare and submit grants to fund research proposals (Research Development). Once a study is open, the Cancer Institute has project management, coordination, regulatory and compliance services that can be accessed for applicable trials. The CRO also has a dedicated research navigator to help guide investigators. Additionally, the Clinical Research Office offers an extensive library of training to new investigators to help support their success as Principal Investigators. Contact Julie Thomas, assistant director of talent development, to learn more.

Who should be contacted as soon as a PI becomes aware of a trial opportunity?

Protocol Activation Coordinating (PAC) Team: Protocol_Activiation@cancer.ufl.edu

Can a PI request or provide a protocol to anyone outside of UF prior to alerting PAC?

No.

Can a PI sign a Confidentiality Disclosure Agreement (CDA) or other documents unless requested by the PAC team?

No.

Should a PI agree to participate in a study, even informally, with a sponsor prior to contacting the PAC team?

No.